Table 1. Breast cancer patient clinical data from TCGA.
| Characteristics |
Caucasian American (n=574)
|
African American (n=53)
|
Fisher's Exact Test | ||
|---|---|---|---|---|---|
| Number | Pct. | Number | Pct. | P-value | |
| Age | 0.603 | ||||
| < 50 | 157 | 27.35% | 18 | 33.96% | |
| 50-64 | 252 | 43.90% | 21 | 39.62% | |
| 65+ | 165 | 28.75% | 14 | 26.42% | |
| Tumor Stage | 0.783 | ||||
| 1 | 117 | 20.38% | 11 | 20.75% | |
| 2 | 337 | 58.71% | 29 | 54.72% | |
| 3 | 120 | 20.91% | 13 | 24.53% | |
| Tumor Type | 0.003 | ||||
| Luminal A | 243 | 42.33% | 16 | 30.19% | |
| Luminal B | 62 | 10.80% | 0 | 0.00% | |
| Triple Negative | 67 | 11.67% | 10 | 18.87% | |
| HER2 Type | 17 | 2.96% | 3 | 5.66% | |
| Other/NA | 185 | 32.23% | 24 | 45.28% | |
| Vital Status | 0.066 | ||||
| Living | 515 | 89.72% | 43 | 81.13% | |
| Deceased | 59 | 10.28% | 10 | 18.87% | |